SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-17-000013
Filing Date
2017-11-07
Accepted
2017-11-07 07:28:00
Documents
62
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20170930x10q.htm 10-Q 961205
2 EXHIBIT 10.1 ex-101amendment3toinfiinka.htm EX-10.1 22569
3 EXHIBIT 10.2 ex-102takedaconvertiblepro.htm EX-10.2 81424
4 EXHIBIT 31.1 ex-311q32017.htm EX-31.1 10544
5 EXHIBIT 31.2 ex-312q32017.htm EX-31.2 11791
6 EXHIBIT 32.1 ex-321q32017.htm EX-32.1 6176
7 EXHIBIT 32.2 ex-322q32017.htm EX-32.2 6217
  Complete submission text file 0001113148-17-000013.txt   4504097

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT infi-20170930.xml EX-101.INS 708611
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20170930.xsd EX-101.SCH 44489
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20170930_cal.xml EX-101.CAL 65421
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20170930_def.xml EX-101.DEF 188045
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20170930_lab.xml EX-101.LAB 518977
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20170930_pre.xml EX-101.PRE 292139
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 171181100
SIC: 2834 Pharmaceutical Preparations